These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 8640349

  • 1. A re-evaluation of the role of alpha 2-adrenoceptors in the anxiogenic effects of yohimbine, using the selective antagonist delequamine in the rat.
    Redfern WS, Williams A.
    Br J Pharmacol; 1995 Oct; 116(3):2081-9. PubMed ID: 8640349
    [Abstract] [Full Text] [Related]

  • 2. Modulation of sexual behaviour in the rat by a potent and selective alpha 2-adrenoceptor antagonist, delequamine (RS-15385-197).
    Tallentire D, McRae G, Spedding M, Clark R, Vickery B.
    Br J Pharmacol; 1996 May; 118(1):63-72. PubMed ID: 8733577
    [Abstract] [Full Text] [Related]

  • 3. Interactions of alpha 2-adrenoceptor antagonists with medetomidine and with ethanol in a holeboard test.
    Durcan MJ, Lister RG, Linnoila M.
    Neuropharmacology; 1989 Mar; 28(3):275-81. PubMed ID: 2566945
    [Abstract] [Full Text] [Related]

  • 4. The alpha-2 antagonists idazoxan and rauwolscine but not yohimbine or piperoxan are anxiolytic in the Vogel lick-shock conflict paradigm following intravenous administration.
    La Marca S, Dunn RW.
    Life Sci; 1994 Mar; 54(10):PL179-84. PubMed ID: 7906377
    [Abstract] [Full Text] [Related]

  • 5. Anxiogenic-like effects of yohimbine and idazoxan in two behavioral situations in mice.
    Venault P, Jacquot F, Save E, Sara S, Chapouthier G.
    Life Sci; 1993 Mar; 52(7):639-45. PubMed ID: 8094225
    [Abstract] [Full Text] [Related]

  • 6. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
    Brown CM, MacKinnon AC, Redfern WS, Hicks PE, Kilpatrick AT, Small C, Ramcharan M, Clague RU, Clark RD, MacFarlane CB.
    Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
    [Abstract] [Full Text] [Related]

  • 7. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour.
    Handley SL, Mithani S.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):1-5. PubMed ID: 6149466
    [Abstract] [Full Text] [Related]

  • 8. Modulatory effects of the basolateral amygdala α2-adrenoceptors on nicotine-induced anxiogenic-like behaviours of rats in the elevated plus maze.
    Bashiri H, Rezayof A, Sahebgharani M, Tavangar SM, Zarrindast MR.
    Neuropharmacology; 2016 Jun; 105():478-486. PubMed ID: 26878830
    [Abstract] [Full Text] [Related]

  • 9. Behavioral effects of alpha 2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice.
    Durcan MJ, Lister RG, Linnoila M.
    Psychopharmacology (Berl); 1989 Jun; 97(2):189-93. PubMed ID: 2567025
    [Abstract] [Full Text] [Related]

  • 10. Modulation of central noradrenergic function by RS-15385-197.
    Redfern WS, MacKinnon AC, Brown CM, Martin AB, Kilpatrick AT, Clague RU, Spedding M.
    Br J Pharmacol; 1993 Feb; 108(2):526-33. PubMed ID: 8095421
    [Abstract] [Full Text] [Related]

  • 11. Anxiolytic-like effects of yohimbine in the murine plus-maze: strain independence and evidence against alpha 2-adrenoceptor mediation.
    Cole JC, Burroughs GJ, Laverty CR, Sheriff NC, Sparham EA, Rodgers RJ.
    Psychopharmacology (Berl); 1995 Apr; 118(4):425-36. PubMed ID: 7568629
    [Abstract] [Full Text] [Related]

  • 12. The differential effects of prenatal stress in rats on the acoustic startle reflex under baseline conditions and in response to anxiogenic drugs.
    White DA, Birkle DL.
    Psychopharmacology (Berl); 2001 Mar 01; 154(2):169-76. PubMed ID: 11314679
    [Abstract] [Full Text] [Related]

  • 13. Comparison of acute and chronic treatment of various serotonergic agents with those of diazepam and idazoxan in the rat elevated X-maze.
    Wright IK, Heaton M, Upton N, Marsden CA.
    Psychopharmacology (Berl); 1992 Mar 01; 107(2-3):405-14. PubMed ID: 1352058
    [Abstract] [Full Text] [Related]

  • 14. The alpha 2-adrenoceptor antagonist atipamezole potentiates anti-Parkinsonian effects and can reduce the adverse cardiovascular effects of dopaminergic drugs in rats.
    Haapalinna A, Leino T, Heinonen E.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Nov 01; 368(5):342-51. PubMed ID: 14566451
    [Abstract] [Full Text] [Related]

  • 15. Yohimbine disrupts prepulse inhibition in rats via action at 5-HT1A receptors, not alpha2-adrenoceptors.
    Powell SB, Palomo J, Carasso BS, Bakshi VP, Geyer MA.
    Psychopharmacology (Berl); 2005 Jul 01; 180(3):491-500. PubMed ID: 15719216
    [Abstract] [Full Text] [Related]

  • 16. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
    Eroğlu L, Güven O.
    Pharmacol Res; 1998 Feb 01; 37(2):137-43. PubMed ID: 9572069
    [Abstract] [Full Text] [Related]

  • 17. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
    Doxey JC, Roach AG, Strachan DA, Virdee NK.
    Br J Pharmacol; 1984 Nov 01; 83(3):713-22. PubMed ID: 6150740
    [Abstract] [Full Text] [Related]

  • 18. Temporary inactivation of the rostral perirhinal cortex induces an anxiolytic-like effect on the elevated plus-maze and on the yohimbine-enhanced startle response.
    Schulz-Klaus B, Fendt M, Schnitzler HU.
    Behav Brain Res; 2005 Sep 08; 163(2):168-73. PubMed ID: 16029901
    [Abstract] [Full Text] [Related]

  • 19. Alpha 2-adrenoceptor antagonists and male sexual behavior: I. Mating behavior.
    Smith ER, Lee RL, Schnur SL, Davidson JM.
    Physiol Behav; 1987 Sep 08; 41(1):7-14. PubMed ID: 2891151
    [Abstract] [Full Text] [Related]

  • 20. Behavioural effects of the alpha 2-adrenoceptor antagonists idazoxan and yohimbine in rats: comparisons with amphetamine.
    Sanger DJ.
    Psychopharmacology (Berl); 1988 Sep 08; 96(2):243-9. PubMed ID: 2906748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.